MAZE
Maze Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.97 / 10
Outperform
Money flow is robust at 7.89/10, with positive block, medium, and large inflows outweighing minor small and extra-large outflows. Analyst sentiment is overwhelmingly bullish (Strong Buy rating from one source, 100% historical win rate). This combination of strong fund flow and bullish analyst view provides a supportive backdrop, but it currently offsets rather than overpowers the weak technicals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-16
InstitutionBTIG
Times predicted4
Historical Win Rate100.0%
What is the market sentiment for MAZE?
- MAZE holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.97/10 (Outperform).
